Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q1 2024 Earnings

26FebConfirmed

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-0.83

-0.76

-0.69

-0.62

Details

Expected EPS

-0.76

Actual EPS

-0.83

Surprise EPS

-0.07

Surprise Percent

+9.21%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.83 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.